About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals Inc. (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company's product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; Vaprisol (conivaptan) Injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Hepatoren (ifetroban) Injection, and Boxaban (ifetroban) oral capsules for the treatment of patients with aspirin-exacerbated respiratory disease (AERD).
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Drug Manufacturers - Other
- Sub-Industry: Pharmaceuticals
- Exchange: NASDAQ
- Symbol: CPIX
- CUSIP: 23077010
- Previous Close: $5.71
- 50 Day Moving Average: $5.97
- 200 Day Moving Average: $5.24
- 52-Week Range: $4.20 - $6.73
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 63.44
- P/E Growth: 0.00
- Market Cap: $92.39M
- Outstanding Shares: 16,180,000
- Beta: 1.36
- Net Margins: -0.14%
- Return on Equity: 1.46%
- Return on Assets: 1.22%
Companies Related to Cumberland Pharmaceuticals:
- Debt-to-Equity Ratio: 0.05%
- Current Ratio: 5.73%
- Quick Ratio: 5.31%
Consensus Ratings for Cumberland Pharmaceuticals (NASDAQ:CPIX) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
No equities research coverage for this company has been tracked by MarketBeat.com
What is Cumberland Pharmaceuticals' stock symbol?
Cumberland Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPIX."
When will Cumberland Pharmaceuticals announce their earnings?
Cumberland Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Wednesday, March, 1st 2017.
Who owns Cumberland Pharmaceuticals stock?
Cumberland Pharmaceuticals' stock is owned by many different of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (5.27%), Stonepine Capital Management LLC (3.83%), Renaissance Technologies LLC (1.59%), Bard Associates Inc. (0.57%) and United Capital Financial Advisers LLC (0.23%). Company insiders that own Cumberland Pharmaceuticals stock include Michael Bonner and Thomas R Lawrence.
Who sold Cumberland Pharmaceuticals stock? Who is selling Cumberland Pharmaceuticals stock?
Cumberland Pharmaceuticals' stock was sold by a variety of institutional investors in the last quarter, including United Capital Financial Advisers LLC and Bard Associates Inc..
Who bought Cumberland Pharmaceuticals stock? Who is buying Cumberland Pharmaceuticals stock?
Cumberland Pharmaceuticals' stock was acquired by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC, Renaissance Technologies LLC and Dimensional Fund Advisors LP.
How do I buy Cumberland Pharmaceuticals stock?
Shares of Cumberland Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Cumberland Pharmaceuticals stock cost?
One share of Cumberland Pharmaceuticals stock can currently be purchased for approximately $5.71.